FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895067322> ?p ?o ?g. }

• W2895067322 endingPage "153" @default.
• W2895067322 startingPage "145" @default.
• W2895067322 abstract "Severe, chronic eye allergy is an understudied, vision-threatening condition. Treatments remain limited. We used a mouse model of severe allergic eye disease (AED) to determine whether topical application of the pro-resolution mediator Resolvin D1 (RvD1) terminates the response. AED was induced by injection of ovalbumin (OVA) followed by topical challenge of OVA daily. RvD1 was applied topically prior to OVA. Clinical symptoms were scored. Eye washes were assayed for MUC5AC. After 7 days, eyes were removed and the number of goblet cells, T helper cell responses and presence of immune cells in draining lymph nodes and conjunctiva determined. Topical RvD1 treatment significantly reduced symptoms of AED. RvD1 did not alter the systemic type 2 immune response in the lymph nodes. AED increased the total amount of goblet cell mucin secretion, but not the number of goblet cells. RvD1 prevented this increase, but did not alter goblet cell number. Absolute numbers of CD4 + T cells, total CD11b + myeloid cells, eosinophils, neutrophils, and monocytes, but not macrophages increased in AED versus RvD1-treated mice. We conclude that topical application of RvD1 reduced the ocular allergic response by local actions in conjunctival immune response and a decrease in goblet cell mucin secretion." @default.
• W2895067322 created "2018-10-12" @default.
• W2895067322 creator A5021848689 @default.
• W2895067322 creator A5028226121 @default.
• W2895067322 creator A5029525374 @default.
• W2895067322 creator A5039527047 @default.
• W2895067322 creator A5045594428 @default.
• W2895067322 creator A5053947826 @default.
• W2895067322 creator A5058670745 @default.
• W2895067322 creator A5059004253 @default.
• W2895067322 creator A5073679755 @default.
• W2895067322 creator A5090413480 @default.
• W2895067322 date "2019-01-01" @default.
• W2895067322 modified "2023-10-14" @default.
• W2895067322 title "Resolvin D1 treatment on goblet cell mucin and immune responses in the chronic allergic eye disease (AED) model" @default.
• W2895067322 cites W1133955507 @default.
• W2895067322 cites W1175418542 @default.
• W2895067322 cites W1514995438 @default.
• W2895067322 cites W1530640702 @default.
• W2895067322 cites W1563042323 @default.
• W2895067322 cites W1600973919 @default.
• W2895067322 cites W1973462155 @default.
• W2895067322 cites W1975390209 @default.
• W2895067322 cites W1976571608 @default.
• W2895067322 cites W1984062427 @default.
• W2895067322 cites W1989094823 @default.
• W2895067322 cites W1997810399 @default.
• W2895067322 cites W1999224453 @default.
• W2895067322 cites W2011024176 @default.
• W2895067322 cites W2016099512 @default.
• W2895067322 cites W2023304501 @default.
• W2895067322 cites W2023995274 @default.
• W2895067322 cites W2031533923 @default.
• W2895067322 cites W2042123099 @default.
• W2895067322 cites W2059172608 @default.
• W2895067322 cites W2061845364 @default.
• W2895067322 cites W2063852954 @default.
• W2895067322 cites W2070033983 @default.
• W2895067322 cites W2073775017 @default.
• W2895067322 cites W2080389273 @default.
• W2895067322 cites W2082952072 @default.
• W2895067322 cites W2086532125 @default.
• W2895067322 cites W2095701392 @default.
• W2895067322 cites W2105296943 @default.
• W2895067322 cites W2112421427 @default.
• W2895067322 cites W2113534429 @default.
• W2895067322 cites W2131458900 @default.
• W2895067322 cites W2135957946 @default.
• W2895067322 cites W2138696540 @default.
• W2895067322 cites W2157016916 @default.
• W2895067322 cites W2162465757 @default.
• W2895067322 cites W2202085130 @default.
• W2895067322 cites W2259200932 @default.
• W2895067322 cites W2264148261 @default.
• W2895067322 cites W2285368336 @default.
• W2895067322 cites W2332025644 @default.
• W2895067322 cites W2339067466 @default.
• W2895067322 cites W2483087589 @default.
• W2895067322 cites W2497192058 @default.
• W2895067322 cites W2517461385 @default.
• W2895067322 cites W2520447320 @default.
• W2895067322 cites W2553878238 @default.
• W2895067322 cites W2560124981 @default.
• W2895067322 cites W2578139631 @default.
• W2895067322 cites W2579756956 @default.
• W2895067322 cites W2593091324 @default.
• W2895067322 cites W2597925028 @default.
• W2895067322 cites W2810560287 @default.
• W2895067322 cites W2887526850 @default.
• W2895067322 cites W30473474 @default.
• W2895067322 cites W48861127 @default.
• W2895067322 cites W610901211 @default.
• W2895067322 doi "https://doi.org/10.1038/s41385-018-0089-1" @default.
• W2895067322 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6301119" @default.
• W2895067322 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30279513" @default.
• W2895067322 hasPublicationYear "2019" @default.
• W2895067322 type Work @default.
• W2895067322 sameAs 2895067322 @default.
• W2895067322 citedByCount "21" @default.
• W2895067322 countsByYear W28950673222019 @default.
• W2895067322 countsByYear W28950673222020 @default.
• W2895067322 countsByYear W28950673222021 @default.
• W2895067322 countsByYear W28950673222022 @default.
• W2895067322 countsByYear W28950673222023 @default.
• W2895067322 crossrefType "journal-article" @default.
• W2895067322 hasAuthorship W2895067322A5021848689 @default.
• W2895067322 hasAuthorship W2895067322A5028226121 @default.
• W2895067322 hasAuthorship W2895067322A5029525374 @default.
• W2895067322 hasAuthorship W2895067322A5039527047 @default.
• W2895067322 hasAuthorship W2895067322A5045594428 @default.
• W2895067322 hasAuthorship W2895067322A5053947826 @default.
• W2895067322 hasAuthorship W2895067322A5058670745 @default.
• W2895067322 hasAuthorship W2895067322A5059004253 @default.
• W2895067322 hasAuthorship W2895067322A5073679755 @default.
• W2895067322 hasAuthorship W2895067322A5090413480 @default.
• W2895067322 hasBestOaLocation W28950673221 @default.
• W2895067322 hasConcept C141105273 @default.
• W2895067322 hasConcept C142724271 @default.

• next